financetom
Business
financetom
/
Business
/
Elastic's CEO Ashutosh Kulkarni believes Generative AI is the next major tech shift in search
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Elastic's CEO Ashutosh Kulkarni believes Generative AI is the next major tech shift in search
Oct 3, 2023 12:09 PM

Ashutosh Kulkarni, the Global CEO of Elastic, expresses strong optimism regarding the transformative potential of generative artificial intelligence (Gen-AI). He firmly believes that generative AI is reshaping the boundaries of what's achievable and enhancing user-friendliness in the realm of search technology.

"Generative AI is truly changing the art of the possible. The beauty of search has always been that it has allowed people to access information in very natural ways. Search is very user friendly and that is what has made it such a wonderful way to access information and what Gen-AI is doing is, it is making search even more user friendly. Now you can have a conversation with the system and have it provide just the right information to you and so that unlocks all kinds of use cases, improves the efficiency of different business processes. I personally believe that Gen-AI is going to be the same kind of major technology shift as we saw with Cloud computing in the past. So I am very bullish on it," Kulkarni said in an interview to CNBC-TV18.

Elastic, an open-source company, offers a comprehensive suite of solutions aimed at helping businesses tackle challenges associated with unstructured and semi-structured data. Recently, the company unveiled Elastic AI Assistant for Observability, a solution harnessing generative AI and the ElasticSearch Relevance Engine (ESRE). This innovation provides human site reliability engineers (SREs) with enriched context concerning application errors, log messages, and alerts, all while suggesting improvements in code efficiency.

Furthermore, Infinity Learn, an edtech platform owned by the Sri Chaitanya group, reported significant financial growth. In FY23, the platform achieved profitability with revenue reaching Rs 100 crore, a remarkable surge from Rs 2.3 crore the previous year. Notably, the platform had recorded a loss of Rs 37 crores in FY22. Ujjwal Singh, the Founder-CEO & President of Infinity Learn, articulated the company's ambitious goal of reaching 50 million learners, with one million of them being paid subscribers, on its platform by 2025. Presently, Infinity Learn boasts over 7,50,000 subscribers and serves a user base of seven million learners.

In addition, CNBC-TV18's Aishwarya Anand presents a report on how SmartStaff, a skilling and blue-collar staffing platform, is empowering gig workers by imparting valuable skills and enabling them to attain financial independence within its manufacturing units.

Watch the accompanying video for more

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Marker Therapeutics Stock Drops After Report About Lymphoma Treatment
Marker Therapeutics Stock Drops After Report About Lymphoma Treatment
Aug 26, 2025
Marker Therapeutics, Inc. ( MRKR ) on Tuesday provided an update on the progress and clinical observations from the Phase 1 APOLLO study investigating MT-601, a Multi-Antigen Recognizing (MAR)-T cell product, in patients with lymphoma who have relapsed after anti-CD19 CAR-T cell therapy or for whom anti-CD19 CAR-T cell therapy is not an option. Last year, Marker Therapeutics ( MRKR...
Regeneron Advances In Rare Disease Race With Positive Autoimmune Muscle Disorder Trial Data
Regeneron Advances In Rare Disease Race With Positive Autoimmune Muscle Disorder Trial Data
Aug 26, 2025
Regeneron Pharmaceuticals, Inc. ( REGN ) on Tuesday shared data from the Phase 3 NIMBLE trial assessing investigational cemdisiran monotherapy in adults with generalized myasthenia gravis (gMG). gMG is a rare, chronic autoimmune disease that causes weakness in voluntary muscles, affecting the eyes, face, neck, arms, legs, and breathing. The trial met the primary and key secondary endpoints. Cemdisiran is...
What's Going On With ImmunityBio Shares Tuesday?
What's Going On With ImmunityBio Shares Tuesday?
Aug 26, 2025
ImmunityBio, Inc. ( IBRX ) shares are trading higher Tuesday after the company announced its chemotherapy-free combination showed 100% disease control results and is planning a Phase 2 trial. What To Know: ImmunityBio ( IBRX ) reported early findings from five patients with recurrent glioblastoma, a deadly form of brain cancer, who were treated with its immune-boosting regimen combining ANKTIVA,...
Stellantis paid $190.6 million in US fuel economy penalties this year, agency says
Stellantis paid $190.6 million in US fuel economy penalties this year, agency says
Aug 26, 2025
(Reuters) -Chrysler-parent Stellantis paid $190.6 million in penalties this year for not meeting U.S. fuel economy requirements, according to a government report and the Italian-American automaker.  The National Highway Traffic Safety Administration said in an annual report that Stellantis paid $112.3 million in June and $78.3 million in March in payments for shortfalls from the 2019 and 2020 model years....
Copyright 2023-2026 - www.financetom.com All Rights Reserved